YVETTE DANCEL: Open Payments
NPI 1780309252 · VINELAND, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 21 payments from 14 companies in 2025. Trend: 2023 $272 · 2024 $832 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Lilly USA, LLC | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Novo Nordisk Inc | 2 | $34 |
| Exact Sciences Corporation | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
Products named: KISUNLA, AIRSUPRA, REXULTI, Ozempic, Cologuard Collection Kit, Auvelity, VRAYLAR, GEMTESA.
Industry payments across NJ — which companies pay providers there.
